• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性血脂异常。特殊考量。

Dyslipoproteinemia in women. Special considerations.

作者信息

Miller V T

机构信息

George Washington University Medical Center, Lipid Research Center, Washington, DC.

出版信息

Endocrinol Metab Clin North Am. 1990 Jun;19(2):381-98.

PMID:2192879
Abstract

Heart disease is the number one cause of death in women, as it is in men; risk factors include high cholesterol, high triglycerides, low HDL-C, diabetes, hypertension, and cigarette smoking. Most of these factors are alterable. The lipoprotein profile of a woman undergoes many changes during her lifetime because of the effects of endogenous hormones at pregnancy, the administration of oral contraceptives, and estrogen replacement at the menopause. Endogenous estrogen reduces the risk of heart disease in women as does unopposed estrogen replacement in the menopause. Oral contraceptives, on the other hand, can increase risk depending on the dose prescribed. Careful attention to a woman's native lipid profile, as well as to the impact of administered hormones on her lipids, is important. It is the responsibility of the physician to help patients achieve and maintain the least atherogenic lipid profile possible as well as to identify and reduce other cardiovascular risk factors.

摘要

心脏病是女性的头号死因,对男性来说也是如此;风险因素包括高胆固醇、高甘油三酯、低高密度脂蛋白胆固醇、糖尿病、高血压和吸烟。这些因素大多是可以改变的。由于孕期内源性激素的影响、口服避孕药的使用以及绝经后雌激素替代治疗,女性的脂蛋白谱在一生中会发生许多变化。内源性雌激素以及绝经后单纯雌激素替代治疗可降低女性患心脏病的风险。另一方面,口服避孕药会根据所开剂量增加风险。密切关注女性自身的血脂情况以及所用激素对其血脂的影响非常重要。医生有责任帮助患者达到并维持尽可能低的致动脉粥样硬化血脂水平,并识别和降低其他心血管风险因素。

相似文献

1
Dyslipoproteinemia in women. Special considerations.女性血脂异常。特殊考量。
Endocrinol Metab Clin North Am. 1990 Jun;19(2):381-98.
2
Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?脂质与心血管疾病:这些研究结果及治疗方法对男性和女性同样适用吗?
Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3. doi: 10.1016/s1049-3867(05)80278-6.
3
[Women and ischemic cardiopathy].[女性与缺血性心脏病]
Rev Clin Esp. 1989 Oct;185(6):308-15.
4
[Cardiovascular risk factors and prevention in women: similarities and differences].[女性心血管危险因素与预防:异同]
Ital Heart J Suppl. 2001 Feb;2(2):125-41.
5
The adverse effects of hormonal therapy.激素疗法的不良反应。
Cardiol Clin. 1986 Feb;4(1):145-52.
6
The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.女性高脂血症的患病率及其与口服避孕药、性激素替代疗法和非脂质冠状动脉疾病危险因素的关联。加拿大心脏健康调查研究小组。
Can J Cardiol. 1999 Apr;15(4):419-27.
7
Cardiovascular effects of oral contraceptives: a review.口服避孕药的心血管效应:综述
Int J Fertil. 1989;34 Suppl:40-9.
8
Effects of sex steroid hormones on lipoprotein levels in pre- and post menopausal women.性类固醇激素对绝经前和绝经后女性脂蛋白水平的影响。
Can J Cardiol. 1990 May;6 Suppl B:31B-35B.
9
Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.与口服避孕药和激素替代疗法相关的脂质和脂蛋白变化。
Fertil Steril. 1988 May;49(5 Suppl 2):39S-50S.
10
Women, lipoproteins, and cardiovascular disease risk.女性、脂蛋白与心血管疾病风险。
Int J Fertil. 1992;37 Suppl 2:63-71.

引用本文的文献

1
The impact of maternal obesity and gestational weight gain on early and mid-pregnancy lipid profiles.母亲肥胖和孕期体重增加对早孕期和中孕期血脂谱的影响。
Obesity (Silver Spring). 2014 Mar;22(3):932-8. doi: 10.1002/oby.20576. Epub 2013 Dec 2.
2
The metabolic syndrome in women.女性的代谢综合征
Nat Clin Pract Endocrinol Metab. 2007 Oct;3(10):696-704. doi: 10.1038/ncpendmet0616.
3
Risk of congenital anomalies in pregnant users of statin drugs.他汀类药物孕期使用者的先天性异常风险。
Br J Clin Pharmacol. 2007 Oct;64(4):496-509. doi: 10.1111/j.1365-2125.2007.02905.x. Epub 2007 May 15.
4
Long-term plasma lipid changes associated with a first birth: the Coronary Artery Risk Development in Young Adults study.首次生育相关的长期血脂变化:青年成人冠状动脉风险发展研究
Am J Epidemiol. 2004 Jun 1;159(11):1028-39. doi: 10.1093/aje/kwh146.
5
Use of lipid-lowering agents (statins) during pregnancy.孕期使用降脂药物(他汀类药物)。
Can Fam Physician. 2003 Jun;49:747-9.
6
Sex steroids and the cardiovascular system.性类固醇与心血管系统。
Osteoporos Int. 1997;7 Suppl 1:S8-11. doi: 10.1007/BF01674806.